Summary

The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (Remicade) and rituximab (Rituxan) – block triggers of inflammation. Biologics may be used alone or in combination with a traditional DMARD to treat autoimmune forms of arthritis, such as RA juvenile idiopathic arthritis (JIA), ankylosing spondylitis or psoriasis/psoriatic arthritis. Biologics are given as an injection or infusion, and as such, there is always a risk of an injection site reaction or an infusion reaction.

Market Analysis and Insights: Global and Japan Anti-inflammatory Biologics Market
This report focuses on global and Japan Anti-inflammatory Biologics market.
In 2020, the global Anti-inflammatory Biologics market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Anti-inflammatory Biologics market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Anti-inflammatory Biologics Scope and Market Size
Anti-inflammatory Biologics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-inflammatory Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Anti-inflammatory Biologics market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Synthetic Type
Biological Type

Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sun Pharmaceutical Industries Ltd
Sanofi
GlaxoSmithKline

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Anti-inflammatory Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Anti-inflammatory Biologics Market Size Growth Rate by Type
1.2.2 Synthetic Type
1.2.3 Biological Type
1.3 Market by Application
1.3.1 Global Anti-inflammatory Biologics Market Size Growth Rate by Application
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Anti-inflammatory Biologics Market Size, Estimates and Forecasts
2.1.1 Global Anti-inflammatory Biologics Revenue 2016-2027
2.1.2 Global Anti-inflammatory Biologics Sales 2016-2027
2.2 Global Anti-inflammatory Biologics, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Anti-inflammatory Biologics Historical Market Size by Region (2016-2021)
2.3.1 Global Anti-inflammatory Biologics Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Anti-inflammatory Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Anti-inflammatory Biologics Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Anti-inflammatory Biologics Sales Forecast by Region (2022-2027)
2.4.2 Global Anti-inflammatory Biologics Revenue Forecast by Region (2022-2027)

3 Global Anti-inflammatory Biologics Competitor Landscape by Players
3.1 Global Top Anti-inflammatory Biologics Manufacturers by Sales
3.1.1 Global Anti-inflammatory Biologics Sales by Manufacturer (2016-2021)
3.1.2 Global Anti-inflammatory Biologics Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Anti-inflammatory Biologics Manufacturers by Revenue
3.2.1 Key Anti-inflammatory Biologics Manufacturers Covered: Ranking by Revenue
3.2.2 Global Anti-inflammatory Biologics Revenue by Manufacturers (2016-2021)
3.2.3 Global Anti-inflammatory Biologics Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Anti-inflammatory Biologics Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Anti-inflammatory Biologics Revenue in 2020
3.2.6 Global Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Anti-inflammatory Biologics Price by Manufacturers
3.4 Global Anti-inflammatory Biologics Manufacturing Base Distribution, Product Types
3.4.1 Anti-inflammatory Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-inflammatory Biologics Product Type
3.4.3 Date of International Manufacturers Enter into Anti-inflammatory Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Anti-inflammatory Biologics Market Size by Type (2016-2021)
4.1.1 Global Anti-inflammatory Biologics Sales by Type (2016-2021)
4.1.2 Global Anti-inflammatory Biologics Revenue by Type (2016-2021)
4.1.3 Anti-inflammatory Biologics Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Anti-inflammatory Biologics Market Size Forecast by Type (2022-2027)
4.2.1 Global Anti-inflammatory Biologics Sales Forecast by Type (2022-2027)
4.2.2 Global Anti-inflammatory Biologics Revenue Forecast by Type (2022-2027)
4.2.3 Anti-inflammatory Biologics Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Anti-inflammatory Biologics Market Size by Application (2016-2021)
5.1.1 Global Anti-inflammatory Biologics Sales by Application (2016-2021)
5.1.2 Global Anti-inflammatory Biologics Revenue by Application (2016-2021)
5.1.3 Anti-inflammatory Biologics Price by Application (2016-2021)
5.2 Anti-inflammatory Biologics Market Size Forecast by Application (2022-2027)
5.2.1 Global Anti-inflammatory Biologics Sales Forecast by Application (2022-2027)
5.2.2 Global Anti-inflammatory Biologics Revenue Forecast by Application (2022-2027)
5.2.3 Global Anti-inflammatory Biologics Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Anti-inflammatory Biologics Market Size YoY Growth 2016-2027
6.1.1 Japan Anti-inflammatory Biologics Sales YoY Growth 2016-2027
6.1.2 Japan Anti-inflammatory Biologics Revenue YoY Growth 2016-2027
6.1.3 Japan Anti-inflammatory Biologics Market Share in Global Market 2016-2027
6.2 Japan Anti-inflammatory Biologics Market Size by Players (International and Local Players)
6.2.1 Japan Top Anti-inflammatory Biologics Players by Sales (2016-2021)
6.2.2 Japan Top Anti-inflammatory Biologics Players by Revenue (2016-2021)
6.3 Japan Anti-inflammatory Biologics Historic Market Review by Type (2016-2021)
6.3.1 Japan Anti-inflammatory Biologics Sales Market Share by Type (2016-2021)
6.3.2 Japan Anti-inflammatory Biologics Revenue Market Share by Type (2016-2021)
6.3.3 Japan Anti-inflammatory Biologics Price by Type (2016-2021)
6.4 Japan Anti-inflammatory Biologics Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Anti-inflammatory Biologics Sales Forecast by Type (2022-2027)
6.4.2 Japan Anti-inflammatory Biologics Revenue Forecast by Type (2022-2027)
6.4.3 Japan Anti-inflammatory Biologics Price Forecast by Type (2022-2027)
6.5 Japan Anti-inflammatory Biologics Historic Market Review by Application (2016-2021)
6.5.1 Japan Anti-inflammatory Biologics Sales Market Share by Application (2016-2021)
6.5.2 Japan Anti-inflammatory Biologics Revenue Market Share by Application (2016-2021)
6.5.3 Japan Anti-inflammatory Biologics Price by Application (2016-2021)
6.6 Japan Anti-inflammatory Biologics Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Anti-inflammatory Biologics Sales Forecast by Application (2022-2027)
6.6.2 Japan Anti-inflammatory Biologics Revenue Forecast by Application (2022-2027)
6.6.3 Japan Anti-inflammatory Biologics Price Forecast by Application (2022-2027)

7 North America
7.1 North America Anti-inflammatory Biologics Market Size YoY Growth 2016-2027
7.2 North America Anti-inflammatory Biologics Market Facts & Figures by Country
7.2.1 North America Anti-inflammatory Biologics Sales by Country (2016-2021)
7.2.2 North America Anti-inflammatory Biologics Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Anti-inflammatory Biologics Market Size YoY Growth 2016-2027
8.2 Asia Pacific Anti-inflammatory Biologics Market Facts & Figures by Region
8.2.1 Asia Pacific Anti-inflammatory Biologics Sales by Region (2016-2021)
8.2.2 Asia Pacific Anti-inflammatory Biologics Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Anti-inflammatory Biologics Market Size YoY Growth 2016-2027
9.2 Europe Anti-inflammatory Biologics Market Facts & Figures by Country
9.2.1 Europe Anti-inflammatory Biologics Sales by Country (2016-2021)
9.2.2 Europe Anti-inflammatory Biologics Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Anti-inflammatory Biologics Market Size YoY Growth 2016-2027
10.2 Latin America Anti-inflammatory Biologics Market Facts & Figures by Country
10.2.1 Latin America Anti-inflammatory Biologics Sales by Country (2016-2021)
10.2.2 Latin America Anti-inflammatory Biologics Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Anti-inflammatory Biologics Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Anti-inflammatory Biologics Market Facts & Figures by Country
11.2.1 Middle East and Africa Anti-inflammatory Biologics Sales by Country (2016-2021)
11.2.2 Middle East and Africa Anti-inflammatory Biologics Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 AbbVie
12.1.1 AbbVie Corporation Information
12.1.2 AbbVie Description and Business Overview
12.1.3 AbbVie Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AbbVie Anti-inflammatory Biologics Products Offered
12.1.5 AbbVie Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Description and Business Overview
12.2.3 Johnson & Johnson Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson & Johnson Anti-inflammatory Biologics Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Amgen Inc
12.3.1 Amgen Inc Corporation Information
12.3.2 Amgen Inc Description and Business Overview
12.3.3 Amgen Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Amgen Inc Anti-inflammatory Biologics Products Offered
12.3.5 Amgen Inc Recent Development
12.4 AstraZeneca PLC
12.4.1 AstraZeneca PLC Corporation Information
12.4.2 AstraZeneca PLC Description and Business Overview
12.4.3 AstraZeneca PLC Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 AstraZeneca PLC Anti-inflammatory Biologics Products Offered
12.4.5 AstraZeneca PLC Recent Development
12.5 Pfizer, Inc
12.5.1 Pfizer, Inc Corporation Information
12.5.2 Pfizer, Inc Description and Business Overview
12.5.3 Pfizer, Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer, Inc Anti-inflammatory Biologics Products Offered
12.5.5 Pfizer, Inc Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Description and Business Overview
12.6.3 Novartis Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Anti-inflammatory Biologics Products Offered
12.6.5 Novartis Recent Development
12.7 Roche
12.7.1 Roche Corporation Information
12.7.2 Roche Description and Business Overview
12.7.3 Roche Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Roche Anti-inflammatory Biologics Products Offered
12.7.5 Roche Recent Development
12.8 Sun Pharmaceutical Industries Ltd
12.8.1 Sun Pharmaceutical Industries Ltd Corporation Information
12.8.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
12.8.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Products Offered
12.8.5 Sun Pharmaceutical Industries Ltd Recent Development
12.9 Sanofi
12.9.1 Sanofi Corporation Information
12.9.2 Sanofi Description and Business Overview
12.9.3 Sanofi Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sanofi Anti-inflammatory Biologics Products Offered
12.9.5 Sanofi Recent Development
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Corporation Information
12.10.2 GlaxoSmithKline Description and Business Overview
12.10.3 GlaxoSmithKline Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.10.4 GlaxoSmithKline Anti-inflammatory Biologics Products Offered
12.10.5 GlaxoSmithKline Recent Development
12.11 AbbVie
12.11.1 AbbVie Corporation Information
12.11.2 AbbVie Description and Business Overview
12.11.3 AbbVie Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AbbVie Anti-inflammatory Biologics Products Offered
12.11.5 AbbVie Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Anti-inflammatory Biologics Industry Trends
13.2 Anti-inflammatory Biologics Market Drivers
13.3 Anti-inflammatory Biologics Market Challenges
13.4 Anti-inflammatory Biologics Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-inflammatory Biologics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer